RABGGTB levels in patients with ALS were analyzed to determine their impact on disease progression.<h4>Results</h4>Using flow cytometry in monocytes and immunofluorescence in macrophages, we found that RABGGTB expression in the ALS group was significantly higher than in the control group. Here, RABGGTB is linked to amyotrophic lateral sclerosis.